Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘Parkinson’s disease’

March 1, 2021

Mayo Clinic Research in the news — 3/1/2021

By Elizabeth Zimmermann Elizabeth Zimmermann

Media coverage of Mayo Clinic research and expertise covered home cancer screening tests, youth vaping, several advancements in women’s health, COVID-19 and many other topics. Read on for excerpts and links to the articles. Putting Faith Into Heart Health  Minnesota Women’s Press, 2/25/2021 Dr. LaPrincess Brewer, a cardiologist at Mayo Clinic in Rochester, grew up […]

View full entry

Tags: addiction research, Alzheimer's disease, Aminah Jatoi, anaphylaxis, arthritis, basic science, bladder cancer, BRCA1, BRCA2, cancer screening, clinical research, cognitive impairment


January 5, 2021

Looking back on 2020: A successful year of research at Mayo Clinic in Florida

By Advancing the Science contributor Advancing the Science contributor

At Mayo Clinic, Research and Education provide the basis for all we are able to do for patients today. Furthermore, they enable practice transformation as we seek to meet future patient needs. From new capabilities in cell therapy and immunotherapy, to advances in neurodegenerative diseases and studies of the virus that causes COVID-19, research at Mayo Clinic continued […]

View full entry

Tags: Alzheimer's disease, Ben Pollock, biomanufacturing, biomarkers, biostatistics, brain, cancer, CAR-T, carbon ion therapy, Center for Regenerative Medicine, chemotherapy, clinical research


October 26, 2020

Mayo Clinic Research in the news — 10/26/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]

View full entry

Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia


February 3, 2020

Merging minds to accelerate research discovery

By Advancing the Science contributor Advancing the Science contributor

Mayo Clinic and Arizona State University formed the Mayo Clinic and Arizona State University Alliance for Health Care in 2010 to merge minds and accelerate research discoveries, improve patient care through innovation and transform medical education to enhance health outcomes. Highlights of two of the joint research efforts follow. Identifying a blood-based biomarker for early-stage […]

View full entry

Tags: Alzheimer's disease, Arizona State University, basic science, biomarkers, Charles Adler, infectious disease, Michael Sierks, MRSA, Parkinson's disease, Robin Patel


December 18, 2019

10 scientific conversation starters for New Year’s Eve

By Caitlin Doran Caitlin Doran

Never know what to say at New Year’s Eve parties? The Advancing the Science blog is here to help with this top-10 recap of our most popular medical research stories from 2019. Everyone loves talking about their health. So keep this list queued up on your phone for quick reference and you’ll never run out […]

View full entry

Tags: age-related macular degeneration, bile duct cancer, breast cancer, cholangiocarcinoma, chronic lymphocytic leukemia, colon polyp, colorectal cancer, end of life care, gastroenterology, Greg Kutcher, hospice, hypoplastic left heart syndrome


June 26, 2019

Researchers look at possible link between low vitamin B12 and Parkinson’s symptoms

By Advancing the Science contributor Advancing the Science contributor

By Jay Furst Low vitamin B12 levels can worsen some symptoms of Parkinson’s disease, especially postural instability and cognitive impairment, which can lead to falls and injuries, researchers say. Lower vitamin B12 levels also are associated with higher Hoehn-Yahr stage, the tool for assessing disease severity, and neuropathy in Parkinson’s patients. While it’s not clear […]

View full entry

Tags: Mayo Clinic Proceedings, neurology, Parkinson's disease, Rodolfo Savica, Stuart McCarter, vitamin B-12


May 20, 2019

Leading and learning in neurological research

By Advancing the Science contributor Advancing the Science contributor

Mayo shares neurological research and advancements at AAN meeting Among more than 15,000 attendees at the 2019 American Academy of Neurology (AAN) Annual Meeting in Philadelphia, May 4-10, Mayo Clinic had a strong presence. Mayo scientists and clinicians led 38 courses and gave 84 lectures at the world’s largest gathering of neurologists. Nearly 60 Mayo […]

View full entry

Tags: Alejandro Rabinstein, Allen Aksamit Jr., Alyx Porter, Angelman syndrome, autoimmune disorder, brain tumor, Bryan Neth, Christopher Boes, Claudia Lucchinetti, David Dodick, Diego Zaquera Carvalho, Eugene Scharf


September 20, 2018

Gerstner awards boost research into hereditary cancer, Parkinson’s disease

By Susan Buckles Susan Buckles

This article originally appeared on the Mayo Clinic Center for Individualized Medicine blog on August 27, 2018 Creating tools to detect cancer at an early stage and advancing research into the genetic links to Parkinson’s disease are focuses of the 2018 Gerstner Family Career Development Awards. This year’s winners are Niloy ‘Jewel’ Samadder, M.D., a […]

View full entry

Tags: cancer prevention, Center for Individualized Medicine, Fabienne Fiesel, genetic testing, genetics, Mayo Clinic Cancer Center, Niloy "Jewel" Samadder, Parkinson's disease


January 9, 2017

Single Allele Mutation Heightens Risk of Early-Onset Parkinson’s

By Robert Nellis Robert Nellis

A collaboration of 32 researchers in seven countries, led by scientists at Mayo Clinic’s campus in Florida, found that a mutation in only one allele of a Parkinson’s gene, known as PINK1, increases the risk of early-onset disease. The finding, published recently in the journal Brain, addresses a longstanding debate about whether individuals need to […]

View full entry

Tags: gene mutation, neurosciences, Parkinson's disease, Wolfdieter Springer


Contact Us · Privacy Policy